Skip to main content
Have a personal or library account? Click to login
The 3’ End Prothrombin Gene Variants in Serbian Patients with Idiopathic Thrombophilia Cover

The 3’ End Prothrombin Gene Variants in Serbian Patients with Idiopathic Thrombophilia

Balkan Journal of Medical Genetics
Volume 17 (2014): Issue 2 (December 2014)
By: ,  ,  ,  ,  ,   and    
Open Access
|Apr 2015
References

References

  1. 1. Colman RW, Clowes AW, George JN, Goldhaber SZ, Marder VJ. Overview of hemostasis. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ. Haemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th ed. Philadelphia, PA: Lippincott Wiliams & Wilkins. 2006: 2-15.
    Search in Google Scholar
  2. 2. White RH. The epidemiology of venous thromboembolism. Circulation. 2003; 107(23 Suppl 1): 14-18.
    Open DOISearch in Google Scholar
  3. 3. Rosendaal FR. Venous thrombosis: Prevalence and interaction of risk factors. Haemostasis. 1999; (Suppl S1): S1-S9.
    Open DOISearch in Google Scholar
  4. 4. Griffin JH, Evatt B, Wideman C. Anticoagulant protein C pathway defective in majority of thrombophilia patients. Blood. 1993; 82(7): 1989-1993.
    Open DOISearch in Google Scholar
  5. 5. Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965; 13: 516-530.
    Search in Google Scholar
  6. 6. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protrombin C in congenital thrombotic disease. J Clin Invest. 1981; 68(5): 1370-1373.
    Open DOISearch in Google Scholar
  7. 7. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984; 74(6): 2082-2088.
    Open DOISearch in Google Scholar
  8. 8. Cushman M. Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program 2005: 452-457.
    Open DOISearch in Google Scholar
  9. 9. März W, Nauck M, Wieland H. The molecular mechanisms of inherited thrombophilia. Z Kardiol. 2000; 89(7): 575-586.
    Open DOISearch in Google Scholar
  10. 10. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994; 269(50): 31869-318680.
    Open DOISearch in Google Scholar
  11. 11. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369(6475): 64-66.
    Open DOISearch in Google Scholar
  12. 12. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: Clinical implications. Semin Thromb Hemost. 1998; 24(4): 367-379.
    Open DOISearch in Google Scholar
  13. 13. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, et al. Increased efficiency of mRNA 3’ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet. 2001; 28(4): 389-392.
    Open DOISearch in Google Scholar
  14. 14. Danckwardt S, Hentze MW, Kulozik AE. 3’ End mRNA processing: Molecular mechanisms and implications for health and disease. EMBO J. 2008; 27(3): 482-498.
    Open DOISearch in Google Scholar
  15. 15. Danckwardt S, Gehring NH, Neu-Yilik G, Hundsdoerfer P, Pforsich M, Frede U, et al. The prothrombin 3’ end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. Blood. 2004; 104(2): 428-435.
    Open DOISearch in Google Scholar
  16. 16. Danckwardt S, Hartmann K, Gehring NH, Hentze MW, Kulozik AE. 3’ End processing of the prothrombin mRNA in thrombophilia. Acta Haematol. 2006; 115(3-4): 192-197.
    Open DOISearch in Google Scholar
  17. 17. Flaujac C, Conard J, Horellou MH, Le Flem L, Samama MM. Atypical mutations of the prothrombin gene at positions 20,209 and 20,218, and a novel mutation at position 20,219. Report on 10 patients. J Thromb Haemost. 2007; 5(5): 1064-1068.
    Open DOISearch in Google Scholar
  18. 18. Warshawsky I, Hren C, Sercia L, Shadrach B, Deitcher SR, Newton E, et al. Detection of a novel point mutation of the prothrombin gene at position 20209. Diagn Mol Pathol. 2002; 11(3): 152-156.
    Open DOISearch in Google Scholar
  19. 19. Hooper C, Roberts S, Dowling N, Austin H, Lally C, Whitsett C. The prevalence of the prothrombin gene variant C20209T in African- Americans and Caucasians and lack of association with venous thromboembolism. Thromb Res. 2006; 118(6): 767-768.
    Open DOISearch in Google Scholar
  20. 20. Ceelie H, Bertina RM, van HylckamaVlieg A, Rosendaal FR, Vos HL. Polymorphisms in the prothrom-bin gene and their association with plasma prothrombin levels. Thromb Haemost. 2001; 85(6): 1066-1070.
    Open DOISearch in Google Scholar
  21. 21. Balim Z, Kosova B, Falzon K, Bezzina Wettinger S, Colak Y. Budd-Chiari syndrome in a patient heterozygous for the point mutation C20221T of the prothrombin gene. J Thromb Haemost. 2003; 1(4): 852-853.
    Open DOISearch in Google Scholar
  22. 22. Pérez-Ceballos E, Corral J, Alberca I, Vayá A, Llamas P, Montes R, et al. Prothrombin A19911G and G20210A polymorphisms’ role in thrombosis. J Haematol. 2002; 118(2): 610-614.
    Open DOISearch in Google Scholar
  23. 23. Martinelli I, Battaglioli T, Tosetto A, Legnani C, Sottile L, Ghiotto R, et al. Prothrombin A19911G polymorphism and the risk of venous thromboembolism. J Tromb Haemost. 2006; 4(12): 2582-2586.
    Open DOISearch in Google Scholar
  24. 24. von Ahsen N, Oellerich M. The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system. Blood. 2004; 103(2): 586-593.
    Open DOISearch in Google Scholar
  25. 25. Chinthammitr Y, Vos HL, Rosendaal FR, Doggen CJ. The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large popula-tion-based case-control study. J Thromb Haemost. 2006; 4(12): 2587-2592.
    Open DOISearch in Google Scholar
  26. 26. Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic analysis of idiopathic thrombophilia. Am J Hum Genet. 2000; 67(6): 1452-1459.
    Open DOISearch in Google Scholar
  27. 27. Djordjevic V, Pruner I, Kovac M, Miljic P, Antonijevic N, Kojic S, et al. Three novel 3’ end pro-thrombin gene polymorphisms and their association with thrombophilia (abstract). J Thromb Haemost. 2011; 9(Suppl 2): 873S.
    Search in Google Scholar
DOI: https://doi.org/10.2478/bjmg-2014-0073 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 43 - 48
Published on: Apr 10, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
3’ End prothrombin (FII) gene,
Gene variants,
Thrombophilia
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2015 M. Aradjanski, V. Djordjevic, I. Pruner, B. Tomic, M. Gvozdenov, M. Kovac, D. Radojkovic, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 17 (2014): Issue 2 (December 2014)
Previous article
Next article